122 related articles for article (PubMed ID: 3035588)
1. Inhibition of ribonucleotide reductases encoded by herpes simplex viruses.
Spector T
Pharmacol Ther; 1985; 31(3):295-302. PubMed ID: 3035588
[No Abstract] [Full Text] [Related]
2. Herpes simplex virus ribonucleotide reductase mutants are hypersensitive to acyclovir.
Coen DM; Goldstein DJ; Weller SK
Antimicrob Agents Chemother; 1989 Aug; 33(8):1395-9. PubMed ID: 2552912
[TBL] [Abstract][Full Text] [Related]
3. 2-Acetylpyridine 5-[(dimethylamino)thiocarbonyl]-thiocarbonohydrazone (A1110U), a potent inactivator of ribonucleotide reductases of herpes simplex and varicella-zoster viruses and a potentiator of acyclovir.
Spector T; Harrington JA; Morrison RW; Lambe CU; Nelson DJ; Averett DR; Biron K; Furman PA
Proc Natl Acad Sci U S A; 1989 Feb; 86(3):1051-5. PubMed ID: 2536930
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of herpes simplex virus ribonucleotide reductase by synthetic nonapeptides: a potential antiviral therapy.
Liuzzi M; Scouten E; Ingemarson R
Adv Exp Med Biol; 1992; 312():129-38. PubMed ID: 1325100
[No Abstract] [Full Text] [Related]
5. Herpes simplex type 1 ribonucleotide reductase. Mechanism studies with inhibitors.
Spector T; Jones TE
J Biol Chem; 1985 Jul; 260(15):8694-7. PubMed ID: 2991215
[TBL] [Abstract][Full Text] [Related]
6. Susceptibility of a herpes simplex virus ribonucleotide reductase null mutant to deoxyribonucleosides and antiviral nucleoside analogs.
Yamada Y; Yamamoto N; Daikoku T; Nishiyama Y
Microbiol Immunol; 1991; 35(8):681-6. PubMed ID: 1661366
[TBL] [Abstract][Full Text] [Related]
7. Can ribonucleotide reductase be considered as an effective target for developing antiherpes simplex virus type II (HSV-2) compounds?
Nutter LM; Grill SP; Cheng YC
Biochem Pharmacol; 1985 Mar; 34(6):777-80. PubMed ID: 2983736
[TBL] [Abstract][Full Text] [Related]
8. Ribonucleotide reductase inhibitors as anti-herpes agents.
Wnuk SF; Robins MJ
Antiviral Res; 2006 Sep; 71(2-3):122-6. PubMed ID: 16621038
[TBL] [Abstract][Full Text] [Related]
9. Differential effect of nucleoside analog triphosphates on ribonucleotide reductases from uninfected and herpes simplex virus-infected HeLa cells.
Nakayama K; Ruth JL; Cheng YC
J Virol; 1982 Jul; 43(1):325-7. PubMed ID: 6287006
[TBL] [Abstract][Full Text] [Related]
10. 2-Acetylpyridine thiocarbonohydrazones. Potent inactivators of herpes simplex virus ribonucleotide reductase.
Blumenkopf TA; Harrington JA; Koble CS; Bankston DD; Morrison RW; Bigham EC; Styles VL; Spector T
J Med Chem; 1992 Jun; 35(12):2306-14. PubMed ID: 1319497
[TBL] [Abstract][Full Text] [Related]
11. The inhibition of ribonucleoside diphosphate reductase by hydroxyurea, guanazole and pyrazoloimidazole (IMPY).
Moore EC; Hurlbert RB
Pharmacol Ther; 1985; 27(2):167-96. PubMed ID: 3898152
[No Abstract] [Full Text] [Related]
12. Herpes simplex virus ribonucleotide reductase induced in infected BHK-21/C13 cells: biochemical evidence for the existence of two non-identical subunits, H1 and H2.
Cohen EA; Charron J; Perret J; Langelier Y
J Gen Virol; 1985 Apr; 66 ( Pt 4)():733-45. PubMed ID: 2984316
[TBL] [Abstract][Full Text] [Related]
13. Effect of iron-chelating agents on inhibitors of ribonucleotide reductase.
Cory JG; Lasater L; Sato A
Biochem Pharmacol; 1981 May; 30(9):979-84. PubMed ID: 6786297
[No Abstract] [Full Text] [Related]
14. Herpes and human ribonucleotide reductases. Inhibition by 2-acetylpyridine 5-[(2-chloroanilino)-thiocarbonyl]-thiocarbonohydrazone (348U87).
Spector T; Harrington JA; Porter DJ
Biochem Pharmacol; 1991 Jun; 42(1):91-6. PubMed ID: 1648925
[TBL] [Abstract][Full Text] [Related]
15. Specific inhibition of the subunits of ribonucleotide reductase as a new approach to combination chemotherapy.
Cory JG; Sato A; Lasater L
Adv Enzyme Regul; 1980; 19():139-50. PubMed ID: 7039256
[No Abstract] [Full Text] [Related]
16. Characterization of the active site of ribonucleotide reductase of Escherichia coli, bacteriophage T4 and mammalian cells by inhibition studies with hydroxyurea analogues.
Larsen IK; Sjöberg BM; Thelander L
Eur J Biochem; 1982 Jun; 125(1):75-81. PubMed ID: 7049700
[No Abstract] [Full Text] [Related]
17. Antiviral susceptibility of Herpes simplex viruses and its clinical correlates: a single center's experience.
Rabella N; Otegui M; Labeaga R; Rodríguez P; Margall N; Gurguí M; Prats G
Clin Infect Dis; 2002 Apr; 34(8):1055-60. PubMed ID: 11914993
[TBL] [Abstract][Full Text] [Related]
18. Treatment of acyclovir-resistant herpes simplex and varicella zoster virus infections.
Safrin S
Adv Exp Med Biol; 1996; 394():59-66. PubMed ID: 8815710
[No Abstract] [Full Text] [Related]
19. Hydroxyurea enhances the activity of acyclovir and cidofovir against herpes simplex virus type 1 resistant strains harboring mutations in the thymidine kinase and/or the DNA polymerase genes.
Sergerie Y; Boivin G
Antiviral Res; 2008 Jan; 77(1):77-80. PubMed ID: 17913252
[TBL] [Abstract][Full Text] [Related]
20. Disruption of herpes simplex virus ribonucleotide reductase quaternary structure by peptide inhibitors as a novel approach to antiviral therapy.
Marcello A; Palù G
J Chemother; 1995 Oct; 7(5):403-5. PubMed ID: 8596120
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
